Advancing early gastric cancer detection

Important factors in combating cancer are early detection and accurate assessment of the best course of treatment. In a study published in this issue, Wang et al. identify possible miRNA biomarkers for improved determination of gastric cancer stage and prognosis. In particular, they show increased m...

Descripción completa

Detalles Bibliográficos
Autor principal: Gillen, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Insight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255838/
https://www.ncbi.nlm.nih.gov/pubmed/34081843
http://dx.doi.org/10.1002/2211-5463.13217
_version_ 1783717992236843008
author Gillen, Sarah
author_facet Gillen, Sarah
author_sort Gillen, Sarah
collection PubMed
description Important factors in combating cancer are early detection and accurate assessment of the best course of treatment. In a study published in this issue, Wang et al. identify possible miRNA biomarkers for improved determination of gastric cancer stage and prognosis. In particular, they show increased miR‐194 levels are a predictor of more favourable gastric cancer prognosis, at least in part due to miR‐194 downregulating production of a key protein for cancer development: CCND1.
format Online
Article
Text
id pubmed-8255838
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82558382021-07-12 Advancing early gastric cancer detection Gillen, Sarah FEBS Open Bio Insight Important factors in combating cancer are early detection and accurate assessment of the best course of treatment. In a study published in this issue, Wang et al. identify possible miRNA biomarkers for improved determination of gastric cancer stage and prognosis. In particular, they show increased miR‐194 levels are a predictor of more favourable gastric cancer prognosis, at least in part due to miR‐194 downregulating production of a key protein for cancer development: CCND1. John Wiley and Sons Inc. 2021-07-04 /pmc/articles/PMC8255838/ /pubmed/34081843 http://dx.doi.org/10.1002/2211-5463.13217 Text en © 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Insight
Gillen, Sarah
Advancing early gastric cancer detection
title Advancing early gastric cancer detection
title_full Advancing early gastric cancer detection
title_fullStr Advancing early gastric cancer detection
title_full_unstemmed Advancing early gastric cancer detection
title_short Advancing early gastric cancer detection
title_sort advancing early gastric cancer detection
topic Insight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255838/
https://www.ncbi.nlm.nih.gov/pubmed/34081843
http://dx.doi.org/10.1002/2211-5463.13217
work_keys_str_mv AT gillensarah advancingearlygastriccancerdetection

Ejemplares similares